Adverum Biotechnologies, Inc. financial data

Symbol
ADVM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Cardinal Way, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Avalanche Biotechnologies, Inc. (to 5/10/2016)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 620 % +30.7%
Debt-to-equity 66.2 % -6.25%
Return On Equity -74.5 % +5.32%
Return On Assets -44.8 % +2.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.8M shares -79.4%
Common Stock, Shares, Outstanding 101M shares +1.31%
Entity Public Float 152M USD +32.1%
Common Stock, Value, Issued 2K USD -80%
Weighted Average Number of Shares Outstanding, Basic 20.9M shares +107%
Weighted Average Number of Shares Outstanding, Diluted 20.9M shares +107%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 68.5M USD -21.9%
General and Administrative Expense 39.9M USD -26.4%
Operating Income (Loss) -108M USD +21.6%
Nonoperating Income (Expense) 7.43M USD +51%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -101M USD +24.3%
Income Tax Expense (Benefit) -1.12M USD -1608%
Net Income (Loss) Attributable to Parent -99.9M USD +25.2%
Earnings Per Share, Basic 2.48 USD/shares +71.6%
Earnings Per Share, Diluted 2.48 USD/shares +71.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 127M USD +14.5%
Cash, Cash Equivalents, and Short-term Investments 174M USD +22.8%
Assets, Current 179M USD +21.9%
Property, Plant and Equipment, Net 13M USD -59.3%
Operating Lease, Right-of-Use Asset 51.2M USD -12.1%
Other Assets, Noncurrent 1.16M USD -11.2%
Assets 254M USD +5.13%
Accounts Payable, Current 1.97M USD +39.1%
Liabilities, Current 22.5M USD -49.5%
Operating Lease, Liability, Noncurrent 63.3M USD -3.72%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 85.8M USD -22.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -525K USD +13.4%
Retained Earnings (Accumulated Deficit) -963M USD -11.6%
Stockholders' Equity Attributable to Parent 168M USD +28.1%
Liabilities and Equity 254M USD +5.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.2M USD -3.72%
Net Cash Provided by (Used in) Financing Activities 120M USD
Net Cash Provided by (Used in) Investing Activities -22M USD -202%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 101M shares +1.31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 74.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 129M USD +13.6%
Deferred Tax Assets, Valuation Allowance 205M USD +9.02%
Deferred Tax Assets, Gross 219M USD +5.41%
Operating Lease, Liability 75M USD -17.5%
Payments to Acquire Property, Plant, and Equipment 90K USD +5.88%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -99.8M USD +24.5%
Lessee, Operating Lease, Liability, to be Paid 141M USD -14.8%
Property, Plant and Equipment, Gross 29.4M USD -43.6%
Operating Lease, Liability, Current 10.6M USD -58.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.4M USD -3.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.1M USD -3.47%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 66.2M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.8M USD -3.44%
Deferred Tax Assets, Operating Loss Carryforwards 128M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 24.6M USD -0.53%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.2M USD -3.42%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 13.6M USD -29.6%
Share-based Payment Arrangement, Expense 16.6M USD -11.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%